Joonha Lee1, Keun-Young Shin2, Hyun-Wook Nam2, Minyoung Oh2, Gi Sung Shim2

1Department of Orthopedic Surgery, Seoul National University Boramae Medical Center, Seoul, South Korea
2Department of Orthopedic Surgery, Bundang Jesaeng General Hospital, Seongnam, South Korea

Keywords: Conservative treatment, epidemiology, femoral neck fractures hip fractures, mortality, prognosis.


Objectives: In this study, we aimed to analyze patient mortality rate after non-operative treatment of hip fractures to determine the distribution of causes of death and to compare factors affecting mortality.

Patients and methods: Between January 2013 and March 2019, a total of 93 patients (17 males, 76 females; mean age: 86.0±7.4 years; range, 64 to 98 years) who had hip fractures and were treated non-operatively were analyzed retrospectively. Survival, date of death, and cause of death were collected and analyzed. Baseline demographics, pre-trauma ambulation, pre- and post-trauma residence status, American Society of Anesthesiologists Physical Status (ASA PS) classification, and Parker’s mobility score were compared with one-year mortality rates.

Results: The mean follow-up of survivors was 16.1±11.9 (range, 6.3 to 79.6) months. The mean survival of non-survivors was 4.9±6.1 (range, 0.007 to 27.3) months. The 3-, 6-, 12-, and 24-month mortality rates were 40.9%, 53.3%, 74.4%, and 87.5%, respectively. Respiratory diseases (33.3%) and cardiovascular diseases (13.6%) were the main causes of death among the patients. There was no statistically significant difference between the patients’ age, sex, fracture site, pre-trauma ambulation, pre- and post-trauma residence status, ASA PS classification, Parker’s mobility score, and one-year mortality.

Conclusion: A significant number of patients are still treated non-operatively after hip fractures, and they have a high mortality rate. Efforts and research are needed to reduce mortality and improve the quality of life.

Citation: Lee J, Shin KY, Nam HW, Oh M, Shim GS. Mortality rates of hip fracture patients with non-operative treatment. Jt Dis Relat Surg 2022;33(1):17-23.

Conflict of Interest

The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.

Financial Disclosure

The authors received no financial support for the research and/or authorship of this article.